17 Jul 2018

TELEFLEX TO ACQUIRE QT VASCULAR ASSETS, TAKES OPTION ON CHOCOLATE HEART DCB

QT Vascular has agreed to sell its non-drug coated coronary products to Teleflex, including its Chocolate XD and Glider, with an option to purchase its Chocolate Heart drug-coated coronary balloon catheter which is currently under development. Singapore-based QT Vascular has not released any financial details of the agreement, but said that it

0
17 Jul 2018

SONAVEX RECEIVES FDA CLEARANCE FOR MEDICAL IMAGING DEVICES

Canton, Ohio-based medical device startup Sonavex. A John Hopkin spinout, received clearance from the U.S. Food and Drug Administration to market implantable devices to be used with ultrasound imaging, CEO David Narrow said. The 510(k) clearance means the Johns Hopkins spinout startup has regulatory approval for its initial product. The Echomark devices are designed to

0
16 Jul 2018

WHY IS STILL TAKING SO LONG TO BUILD A STUDY?

  By Nick O’Brien The Tufts Center for the Study of Drug Development released its 2017 eClinical Landscape Study (outsourcing-pharma.com/Article/2017/10/12/Clinical-trial-database-tribulations-stunt-trial-timelines) late last year, and among the results is a troubling statistic. Companies conducting clinical trials are taking an average of 68 days to build their studies, with 77 percent of survey respondents

0
16 Jul 2018

AVINGER RECEIVES FDA CLEARANCE FOR PANTHERIS DEVICE; SHARES AHEAD 47% PREMARKET

Avinger has received 510(k) clearance from the FDA for its next generation Pantheris Lumivascular atherectomy system, the first-ever image-guided atherectomy device for the treatment of peripheral artery disease (P.A.D.). Lumivascular is the only technology that combines real-time intravascular imaging with highly effective catheters for the treatment of P.A.D. The Company intends to launch two versions

0
16 Jul 2018

MED-AESTHETIC SOLUTIONS INC., DEVELOPER OF SALT FACIAL, PARTNERS WITH AESTHETIC MANAGEMENT PARTNERS

Med-Aesthetic Solutions Inc., the developer and manufacturer of the proprietary SaltFacial skin renewal system, has formed a partnership with Aesthetic Management Partners to represent its product line exclusively, in select markets worldwide. The partnership commenced with a strong presence at The Aesthetic Show in Las Vegas in July. Aesthetic Management

0
14 Jul 2018

CMS PROPOSES HISTORIC RULE CHANGE

    The Centers for Medicare & Medicaid Services (CMS) proposed historic changes July 12 that would increase the amount of time that doctors and other clinicians can spend with their patients by reducing the burden of paperwork that clinicians face when billing Medicare. Public comments on the proposed rules

0
08 Jul 2018

GLOBAL CVC MARKET TO GROW AT 3.9%

  The “Global Central Venous Catheters (CVCs) Market 2017-2021” report has been added to Research and Markets’ offering. The CVCs market is expected to grow at a CAGR of 3.94 percent during the period 2017-2021. The report has been prepared based on an in-depth market analysis with inputs from industry

0
08 Jul 2018

NEW VEIN MED CONSULTANTS BOOK TO DEBUT AT CVC ARTERIAL & VENOUS ENDOVASCULAR CONFERENCE JULY 11-13

  “A Guide to Treating Facial Veins,” ‘a “new, one-of-a-kind” book illustrating the safe treatment for all facial veins using anatomical principles, has been published by Ronald Bush, MD, FACS, and Peggy Bush, APRN. The book made its debut at the CVC Arterial & Venous Endovascular Conference at the Radisson

0
26 Jun 2018

DERMAKA HAS NEW ENHANCED NATURAL HEALING FORMULA

  Dermaka cream is an all-natural plant-based product that aids in skin healing, rejuvenation, and substantially reduces redness and bruising. Dermaka cream was developed by Ronald Bush, MD, FACS, to minimize bruising and inflammatory responses of the skin in the post-operative period. While the product has been around for several

0
26 Jun 2018

What is the role of conformity in vein treatment?

  By James R. Williams   Healthcare bleeds conformity. And for the most part, for good reason. Physicians are trained to rely on statistically proven techniques to treat a condition. These techniques become the gold standard. Physicians are taught not to deviate from these standards until empirical evidence of another

0